David
Fitzgibbon
Partner
David is a partner and Co-Head of the Firm’s Corporate Department and Head of the Corporate M&A Group.
He has extensive experience assisting clients across a range of industries on doing business in and from Ireland, including advising on acquisitions/disposals, capital raisings, corporate migrations, cross-border mergers, joint ventures and reorganisations. David has significant experience advising on take-private transactions and has advised on many of Ireland’s most notable transactions.
He has worked with a wide range of domestic and international corporations providing ongoing strategic advice to their boards. He has a broad-based practice reflecting his considerable experience across the agri-food, financial services, healthcare / life sciences and manufacturing sectors.
Experience and Education
David has recently advised:
- Tirlán Co-operative Society Limited on an equity placing of a portion of its shareholding in Glanbia plc (raising gross proceeds of approximately €230m) and the concurrent tender offer to repurchase its outstanding €250m Exchangeable Bond.
- Smurfit Kappa Group plc on its $25.5 billion merger with WestRock Company to form Smurfit Westrock.
- Horizon Therapeutics on all aspects of its acquisition by Amgen for aggregate consideration of $27 billion.
- Zoom Video Communications, Inc on its acquisition of employee communication and engagement platform, Workvivo.
- Novo Nordisk A/S on its acquisition of Neotope Neuroscience Limited for $100 million upfront and up to $1.2 billion in development and sales milestones payments.
- Horizon Therapeutics on its $960 million underwritten public offering of ordinary shares.
- Willis Towers Watson plc on its proposed $80 billion business combination with Aon plc.
- Tirlán Co-operative Society Limited on all aspects of its acquisition of Glanbia plc’s interest in Glanbia Ireland, a dairy processing and consumer goods joint venture formed between Tirlán Co-operative Society Limited and Glanbia plc.
- Tirlán Co-operative Society Limited on all aspects of the funding arrangements for its acquisition of Glanbia plc’s 40% interest in Glanbia Ireland. (raising approximately €310m) comprised of a share placing by Tirlán Co-op of approximately 2% of Glanbia plc’s issued share capital together with the issue by Tirlán Co-op of a €250m equity-linked exchangeable bond.
- Horizon Therapeutics on its acquisition of EirGen Pharma’s manufacturing facility in Waterford.
- Smurfit Kappa Group on its November 2020 €660 million Share Placing.
- Trinity College Dublin (LLB with German)
- Law Society of Ireland, admitted as a solicitor
